Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy.
Xincheng SunXianhuai WangXinyu GuoMengjiao WangHu LiuPublished in: Ophthalmology and therapy (2023)
The combined use of anti-VEGF drugs before and during PPV in patients with severe PDR not only includes the advantages of preoperative injection, but also has more significant prognostic benefits and favourable safety profiles.